Mounjaro, made by US pharmaceutical company Eli Lilly, is vying for market share among a new class of drugs originally designed to treat diabetes which have been shown to aid dramatic weight loss
Subject to final guidance, the once-weekly jab should be prescribed alongside a reduced-calorie diet and exercise, the National Institute for Health and Care Excellence has said. The Nice guidance said Eli Lilly proposes that the drug should be available to those with a BMI of 30 with at least one weight-related condition. However, the NHS spending watchdog said the “most likely cost-effectiveness estimates for this group are above the range that Nice considers an acceptable use of NHS resources”.
A four-week supply of pre-filled pen injections of Mounjaro ranges from £92 for the lowest dose to £122 for the highest. The price of Wegovy ranges from £73.25 to £175.80 per pack, with each pack containing one pen that delivers four doses.
Source: Healthcare Press (healthcarepress.net)
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: i newspaper - 🏆 8. / 89 Read more »
Source: DailyMailCeleb - 🏆 1. / 99 Read more »
Source: DailyMailCeleb - 🏆 1. / 99 Read more »
Source: DailyMailCeleb - 🏆 1. / 99 Read more »
Diabetes drug recommended to treat obesity on the NHSMounjaro was given the green light to be prescribed to type 2 diabetics last year.
Source: Observer_Owl - 🏆 18. / 72 Read more »
Diabetes drug recommended to treat obesity on the NHSMounjaro was given the green light to be prescribed to type 2 diabetics last year.
Source: Glasgow_Times - 🏆 76. / 59 Read more »